About this trial
Investigation of the correlation of CT-morphological changes of the lung compared to regional ventilation distribution on electrical impedance tomography in patients with post-acute-Covid-19 symptoms.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
all patients undergoing a Chest CT due to suspected post-acute-Covid-19-syndrome
>18 years
informed consent.
Disqualifiers
trauma patients and patients with unstable spinal injuries or fractures
patients with an BMI over 50
patients with uncontrolled body movements
Patients with a pacemaker
Trial population
All patients presenting to the post-COVID-19 outpatient clinic are screened.
Trial design
Cohort
Prospective
Treatments tested in this trial
additional EIT Measurement
Diagnostic testPatients who receive standard CT and pulmonary function testing also receive electroimpedance tomography measurement. The lunghealthy Patients in the control group only receive a EIT.
Treatment groups
Trial outcomes
Primary outcomes
Correlation between tomography and electroimpedance tomography
The primary study objective is to match CT morphological changes in regional ventilation in post-COVID patients and/or changes in lung function examination with changes that can be visualized by electroimpedance tomography.
Secondary outcomes
Correlation between lung function testing and electroimpedance tomography
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Jan-Christoph Lewejohann
Lead sponsor
Jena University Hospital
Sponsor institution
This trial is not recruiting at the moment. You can still explore other options: